Swarnali Das Paul

723 total citations
35 papers, 527 citations indexed

About

Swarnali Das Paul is a scholar working on Pharmaceutical Science, Biomaterials and Nutrition and Dietetics. According to data from OpenAlex, Swarnali Das Paul has authored 35 papers receiving a total of 527 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmaceutical Science, 6 papers in Biomaterials and 6 papers in Nutrition and Dietetics. Recurrent topics in Swarnali Das Paul's work include Advanced Drug Delivery Systems (14 papers), Nanoparticle-Based Drug Delivery (6 papers) and Advancements in Transdermal Drug Delivery (5 papers). Swarnali Das Paul is often cited by papers focused on Advanced Drug Delivery Systems (14 papers), Nanoparticle-Based Drug Delivery (6 papers) and Advancements in Transdermal Drug Delivery (5 papers). Swarnali Das Paul collaborates with scholars based in India, Saudi Arabia and Czechia. Swarnali Das Paul's co-authors include Preeti K. Suresh, Trilochan Satapathy, Rishi Paliwal, Rohitas Deshmukh, Ranjit K. Harwansh, Rishikesh Shukla, AK Jha, Rahul Deshmukh, Arvind Kumar Jha and M. Ajazuddin and has published in prestigious journals such as SHILAP Revista de lepidopterología, RSC Advances and Colloids and Surfaces B Biointerfaces.

In The Last Decade

Swarnali Das Paul

31 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Swarnali Das Paul India 12 299 117 99 96 57 35 527
Ebru Başaran Türkiye 13 322 1.1× 125 1.1× 130 1.3× 120 1.3× 62 1.1× 27 541
Guadalupe Abrego Spain 13 381 1.3× 89 0.8× 135 1.4× 182 1.9× 86 1.5× 14 653
Nadia M. Morsi Egypt 11 435 1.5× 103 0.9× 174 1.8× 129 1.3× 47 0.8× 16 668
Giulia Di Prima Italy 14 214 0.7× 87 0.7× 112 1.1× 110 1.1× 32 0.6× 29 478
Helen L. Alvarado Spain 13 379 1.3× 90 0.8× 131 1.3× 191 2.0× 102 1.8× 16 688
Zeinab Fathalla Egypt 9 271 0.9× 74 0.6× 126 1.3× 82 0.9× 21 0.4× 21 472
Rawia M. Khalil Egypt 14 578 1.9× 115 1.0× 122 1.2× 158 1.6× 67 1.2× 34 757
Yanzhong Chen China 14 321 1.1× 113 1.0× 215 2.2× 128 1.3× 34 0.6× 28 587
Carol Yousry Egypt 13 208 0.7× 77 0.7× 58 0.6× 87 0.9× 32 0.6× 20 411
Rofida Albash Egypt 15 420 1.4× 69 0.6× 66 0.7× 143 1.5× 77 1.4× 26 685

Countries citing papers authored by Swarnali Das Paul

Since Specialization
Citations

This map shows the geographic impact of Swarnali Das Paul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Swarnali Das Paul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Swarnali Das Paul more than expected).

Fields of papers citing papers by Swarnali Das Paul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Swarnali Das Paul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Swarnali Das Paul. The network helps show where Swarnali Das Paul may publish in the future.

Co-authorship network of co-authors of Swarnali Das Paul

This figure shows the co-authorship network connecting the top 25 collaborators of Swarnali Das Paul. A scholar is included among the top collaborators of Swarnali Das Paul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Swarnali Das Paul. Swarnali Das Paul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Choudhary, Rajesh, et al.. (2025). Plumbagin Protects Diabetogenic Cataract Formation by Mitigating Lens Aldose Reductase and Oxidative Stress. Journal of pharmacopuncture. 28(3). 191–200.
2.
Begum, Shahnaz, et al.. (2024). Promotion and modulation of amyloid fibrillation of bovine beta-lactoglobulin by hydroxychalcones. Journal of Molecular Structure. 1318. 139164–139164. 2 indexed citations
3.
Begum, Shahnaz, et al.. (2024). Anion–Induced Amyloid Fibrillation of Human Insulin In vitro. ChemistrySelect. 9(13).
4.
5.
Paul, Swarnali Das, et al.. (2023). Exploring potential of diacerin nanogel for topical application in arthritis: Formulation development, QbD based optimization and pre-clinical evaluation. Colloids and Surfaces B Biointerfaces. 223. 113160–113160. 12 indexed citations
6.
Paul, Swarnali Das, et al.. (2023). Overview on Ocular Drug Delivery through Colloidal Nano-Suspension. Research Journal of Pharmacy and Technology. 1533–1539. 5 indexed citations
7.
Begum, Shahnaz, et al.. (2023). Structural modulation of insulin by hydrophobic and hydrophilic molecules. RSC Advances. 13(48). 34097–34106. 5 indexed citations
8.
Mazumder, Rupa, et al.. (2022). NOVEL APPROACHES IN OCULAR DRUG DELIVERY-A REVOLUTION. International Journal of Applied Pharmaceutics. 1–11. 2 indexed citations
9.
Begum, Shahnaz, Swarnali Das Paul, Barun Mondal, et al.. (2022). Coumarin derivatives inhibit the aggregation of β-lactoglobulin. RSC Advances. 12(27). 17020–17028. 14 indexed citations
10.
Paul, Swarnali Das, et al.. (2022). Development and in vitro Evaluation of Atazanavir Microcrystals for Intranasal Delivery. Indian Journal of Pharmaceutical Education and Research. 56(2s). s216–s224. 2 indexed citations
11.
Deshmukh, Rohitas, et al.. (2021). NOVEL DELIVERY APPROACHES OF CO-TRIMOXAZOLE FOR RECREATING ITS POTENTIAL USE-A REVIEW. International Journal of Applied Pharmaceutics. 36–42. 1 indexed citations
12.
Mishra, Sandhya, et al.. (2019). The Functional Nanogel: An Exalted Carrier System. Journal of Drug Delivery and Therapeutics. 9(2-s). 570–582. 7 indexed citations
13.
Ghosh, Souvik, et al.. (2019). Role of vitamin D3 supplementation in allergic rhinitis: an outpatient department based prospective analytical observational study. International Journal of Basic & Clinical Pharmacology. 8(11). 2498–2498. 1 indexed citations
14.
Paul, Swarnali Das. (2015). Editorial (Thematic Issue: Research and Regulation: Challenges of Nanoproducts). 5(1). 1–2. 1 indexed citations
15.
Paul, Swarnali Das, et al.. (2013). An Ex vivo study of Amphotericin-B Nanoparticle for Ocular Delivery. 1(2). 119–125. 1 indexed citations
16.
Paul, Swarnali Das, et al.. (2013). Optimization of Polymeric Nano Drug Delivery System Using 3.<sup>2</sup> Full Factorial Design. Current Drug Delivery. 10(4). 394–403. 2 indexed citations
17.
Paul, Swarnali Das, et al.. (2013). Nanotechnology to Nanotoxicology: A Review Article.
18.
Paul, Swarnali Das & Preeti K. Suresh. (2010). Nanosuspension: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to amphotericin B. Nanomedicine Nanotechnology Biology and Medicine. 7(2). 242–247. 114 indexed citations
19.
Paul, Swarnali Das, Rahul Deshmukh, & AK Jha. (2010). Role of natural polymers in the development of multiparticulate systems for colon drug targeting. Systematic Reviews in Pharmacy. 1(1). 79–79. 26 indexed citations
20.
Paul, Swarnali Das, et al.. (2009). Design of Eudragit RL 100 nanoparticles by nanoprecipitation method for ocular drug delivery. Nanomedicine Nanotechnology Biology and Medicine. 6(2). 318–323. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026